Regional distribution of cyclooxygenase-2 in the hippocampal formation in Alzheimer's disease

Journal of Neuroscience Research

Volumn 57, Issue 3, 1999, Pages 295-303

  Ho, Lap ^a   Pieroni, Cristiana ^a   Winger, David ^a   Purohit, Dushyant P ^a   Aisen, Paul S ^a   Pasinetti, Giulio Maria ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Cyclooxygenase inflammation; NSAIDs; Oxidative stress

Indexed keywords

AMYLOID BETA PROTEIN; CYCLOOXYGENASE 2; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTANOID;

ADULT; AGED; ALZHEIMER DISEASE; ANIMAL CELL; CONTROLLED STUDY; ENZYME LOCALIZATION; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; INFLAMMATION; MOUSE; NEUROPATHOLOGY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; SHORT SURVEY; TISSUE DISTRIBUTION;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; ATROPHY; CASE-CONTROL STUDIES; CYCLOOXYGENASE 2; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HIPPOCAMPUS; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; MALE; MEMBRANE PROTEINS; MICE; MICE, TRANSGENIC; MIDDLE AGED; NEURONS; NEUROTOXINS; PEPTIDE FRAGMENTS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;

EID: 0033178889     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19990801)57:3<295::AID-JNR1>3.0.CO;2-0     Document Type: Short Survey

References (29)

1. Aisen PS, Davis KL. 1994. Inflammatory mechanisms in Alzheimer's disease: implications for therapy. Am J Psychiatry 151:1105-1113.
2. Aisen PS, Davis KL. 1997. The search for disease-modifying treatment for Alzheimer's disease. Neurology 48(Suppl 6):S35-S41.
3. Aisen PS, Pasinetti GM. 1998. Glucocorticoid in Alzheimer's disease: the story so far. Drugs Aging 12:1-6.
4. Benzi G, Moretti A. 1995. Are reactive oxygen species involved in Alzheimer's disease? Neurobiol Aging 16:661-674.
5. Bruce AJ, Malfroy B, Baudry M. 1996. β-Amyloid toxicity in organotypic hippocampal cultures: protection by EUK-8, a synthetic catalytic free radical scavenger. Proc Natl Acad Sci USA 93:2312-2316.
6. Halliwell B, Gutteridge JMC. 1995. Free radicals in biology and medicine. Oxford: Clarendon Press.
7. Henley K, Butterfield DA, Hall N, Cole P, Subramaniam R, Mark R, Mattson MP, Markesbery WR, Harris ME, Aksenov M, Aksenova M, Wu JF, Carney JM. 1996. Reactive oxygen species as causal agents in the neurotoxicity of the Alzheimer's disease-associated amyloid beta peptide. Ann NY Acad Sci 786:120-134.
8. Hewett SJ, Hewett JA. 1997. COX-2 contributes to NMDA-induced neuronal death in cortical cell cultures. Soc Neurosci Abstr 23:1666.
9. Ho L, Kelley K, Blanco C, Aisen PS, Pasinetti GM. 1998a. Transgenic mice with neuronal overexpression of human cyclooxygenase-2: a model of Alzheimer's disease neurodegeneration [abstract]. Soc Neurosci Abstr 24:727.
10. Ho L, Osaka H, Aisen PS, Pasinetti GM. 1998b. Induction of cyclooxygenase (COX)-2 but not COX-1 gene expression in apoptotic cell death. J Neuroimmunol 89:142-149.
11. Kaufmann WE, Worley PF, Pegg J, Bremer M, Isakson P. 1996. COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex. Proc Natl Acad Sci USA 93:2317-2321.
12. Kelley K, Ho L, Winger D, Freire-Moar J, Aisen PS, Pasinetti GM. 1999. Potentiation of excitotoxicity in transgenic mice overexpressing neuronal cyclooxygenase-2 (in press).
13. Khachaturian ZS. 1985. Diagnosis of Alzheimer's disease. Arch Neurol 42:1097-1105.
14. Kitamura Y, Shimohama S, Koike H, Kakimura J, Matsuoka Y, Nomura Y, Gebicke-Haerter P, Taniguchi T. 1999. Increased expression of cyclooxygenases and peroxisome proliferator-activated receptor-γ in Alzheimer's disease brains. Biochem Biophys Res Commun 254:582-586.
15. Lampert-Etchells M, Pasinetti GM, Finch CE, Johnson SA. 1993. Regional localization of cells containing complement C1q and C4 mRNAs in the frontal cortex during Alzheimer's disease. Neurodegeneration 2:111-121.
16. Mackenzie IRA, Munoz DG. 1998. Nonsteroidal anti-inflammatory drug use and Alzheimer-type pathology in aging. Neurology 50:986-990.
17. McGeer PL, Schulzer M, McGeer EG. 1996. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology 47:425-432.
18. Meier-Ruge W, Ulrich J, Stahelin HB. 1985. Morphometric investigation of nerve cells, neuropil and senile plaques in senile dementia of the Alzheimer type. Arch Gerontol Geriatr 4:219-229.
19. Mirra SS. 1997. The CERAD neuropathology protocol and consensus recommendations for the postmortem diagnosis of Alzheimer's disease: a commentary. Neurobiol Aging 18(Suppl):S91-S94
20. Oka A, Takashima S. 1997. Induction of cyclo-oxygenase 2 in brains of patients with Down's syndrome and dementia of Alzheimer type: specific localization in affected neurones and axons. NeuroReport 8:1161-1164.
21. Pasinetti GM. 1998. Cyclooxygenase and inflammation in Alzheimer's disease: experimental approaches and clinical interventions. J Neurosci Res 54:1-6.
22. Pasinetti GM, Aisen PS. 1998. Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain. Neuroscience 87:319-324.
23. Pike CJ, Ramezan-Arab N, Cotman CW. 1997. Beta-amyloid neurotoxicity in vitro: evidence of oxidative stress but not protection by antioxidants. J Neurochem 69:1601-1611.
24. Rogers J, Morrison JH. 1985. Quantitative morphology and regional and laminar distribution of senile plaques in Alzheimer's disease. J Neurosci 5:2801-2808.
25. Rogers J, Kirby LC, Hempelman SR, Berry DL, McGeer PL, Kaszniak AW, Zalinski J, Cofield M, Mansukhani L, Willson P, Kogan F. 1993. Clinical trial of indomethacin in Alzheimer's disease. Neurology 43:1609-1611.
26. Shearman MS, Ragan CI, Iversen LL. 1994. Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of β-amyloid-mediated cell death. Proc Natl Acad Sci USA 91:1470-1474.
27. Tocco G, Freire O, Schreiber SS, Sakhi SH, Aisen PS, Pasinetti GM. 1997. Maturational regulation and regional induction of cyclooxygenase-2 in rat brain: implications for Alzheimer's disease. Exp Neurol 144:339-349.
28. Vane JR, Botting RM. 1995. New insights into the mode of action of anti-inflammatory drugs. Inflam Res 44:1-10.
29. Yamagata K, Andreasson KI, Kaufmann WE, Barnes CA, Worley PF. 1993. Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids. Neuron 11:371-386.